📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. (2017)

First Author: Vennin C

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aai8504

PubMed Identifier: 28381539

Publication URI: http://europepmc.org/abstract/MED/28381539

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 384

ISSN: 1946-6234